Extensive impact of non-antibiotic drugs on human gut bacteria L Maier, M Pruteanu, M Kuhn, G Zeller, A Telzerow, EE Anderson, ... Nature 555 (7698), 623-628, 2018 | 1770 | 2018 |
From the regulation of peptidoglycan synthesis to bacterial growth and morphology A Typas, M Banzhaf, CA Gross, W Vollmer Nature Reviews Microbiology 10 (2), 123-136, 2012 | 1416 | 2012 |
Salt-responsive gut commensal modulates TH17 axis and disease N Wilck, MG Matus, SM Kearney, SW Olesen, K Forslund, ... Nature 551 (7682), 585-589, 2017 | 1181 | 2017 |
Phenotypic landscape of a bacterial cell RJ Nichols, S Sen, YJ Choo, P Beltrao, M Zietek, R Chaba, S Lee, ... Cell 144 (1), 143-156, 2011 | 777 | 2011 |
Recovery of gut microbiota of healthy adults following antibiotic exposure A Palleja, KH Mikkelsen, SK Forslund, A Kashani, KH Allin, T Nielsen, ... Nature microbiology 3 (11), 1255-1265, 2018 | 659 | 2018 |
A new antibiotic selectively kills Gram-negative pathogens Y Imai, KJ Meyer, A Iinishi, Q Favre-Godal, R Green, S Manuse, M Caboni, ... Nature 576 (7787), 459-464, 2019 | 624 | 2019 |
Construction and analysis of two genome-scale deletion libraries for Bacillus subtilis BM Koo, G Kritikos, JD Farelli, H Todor, K Tong, H Kimsey, I Wapinski, ... Cell systems 4 (3), 291-305. e7, 2017 | 554 | 2017 |
Selective ribosome profiling reveals the cotranslational chaperone action of trigger factor in vivo E Oh, AH Becker, A Sandikci, D Huber, R Chaba, F Gloge, RJ Nichols, ... Cell 147 (6), 1295-1308, 2011 | 516 | 2011 |
Country-specific antibiotic use practices impact the human gut resistome K Forslund, S Sunagawa, JR Kultima, DR Mende, M Arumugam, A Typas, ... Genome research 23 (7), 1163-1169, 2013 | 452 | 2013 |
Regulation of peptidoglycan synthesis by outer-membrane proteins A Typas, M Banzhaf, BB van Saparoea, J Verheul, J Biboy, RJ Nichols, ... Cell 143 (7), 1097-1109, 2010 | 421 | 2010 |
Species-specific activity of antibacterial drug combinations AR Brochado, A Telzerow, J Bobonis, M Banzhaf, A Mateus, J Selkrig, ... Nature 559 (7713), 259-263, 2018 | 337 | 2018 |
Yeast creates a niche for symbiotic lactic acid bacteria through nitrogen overflow O Ponomarova, N Gabrielli, DC Sévin, M Mülleder, K Zirngibl, K Bulyha, ... Cell systems 5 (4), 345-357. e6, 2017 | 314 | 2017 |
High-throughput, quantitative analyses of genetic interactions in E. coli A Typas, RJ Nichols, DA Siegele, M Shales, SR Collins, B Lim, H Braberg, ... Nature methods 5 (9), 781-787, 2008 | 296 | 2008 |
Emerging and evolving concepts in gene essentiality G Rancati, J Moffat, A Typas, N Pavelka Nature Reviews Genetics 19 (1), 34-49, 2018 | 265 | 2018 |
A dual-mechanism antibiotic kills gram-negative bacteria and avoids drug resistance JK Martin, JP Sheehan, BP Bratton, GM Moore, A Mateus, SHJ Li, H Kim, ... Cell 181 (7), 1518-1532. e14, 2020 | 255 | 2020 |
Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies M Tramontano, S Andrejev, M Pruteanu, M Klünemann, M Kuhn, ... Nature microbiology 3 (4), 514-522, 2018 | 249 | 2018 |
Host-microbe co-metabolism dictates cancer drug efficacy in C. elegans TA Scott, LM Quintaneiro, P Norvaisas, PP Lui, MP Wilson, KY Leung, ... Cell 169 (3), 442-456. e18, 2017 | 249 | 2017 |
Unravelling the collateral damage of antibiotics on gut bacteria L Maier, CV Goemans, J Wirbel, M Kuhn, C Eberl, M Pruteanu, P Müller, ... Nature 599 (7883), 120-124, 2021 | 243 | 2021 |
Fe-S cluster biosynthesis controls uptake of aminoglycosides in a ROS-less death pathway B Ezraty, A Vergnes, M Banzhaf, Y Duverger, A Huguenot, AR Brochado, ... Science 340 (6140), 1583-1587, 2013 | 243 | 2013 |
Bioaccumulation of therapeutic drugs by human gut bacteria M Klünemann, S Andrejev, S Blasche, A Mateus, P Phapale, ... Nature 597 (7877), 533-538, 2021 | 220 | 2021 |